Mr. Wu Guojia (吴国佳), aged 47, was appointed as our Vice President on March 15, 2018 when he joined our Group, and was appointed as an executive Director and director of MP CardioFlow on September 29, 2020. He is responsible for sales and marketing and participating in the management and strategic development of our Group.
Mr. Wu has more than 16 years of experience in medical device companies and more than 6years of experience as an interventional cardiologist, obtained attending doctor license. Before joining us, Mr. Wu has been working as a clinical training manager at BSC International Medical Trading(Shanghai) Co., Limited, a subsidiary of Boston Scientific Corporation, a medical device company listed on the New York Stock Exchange (ticker symbol: BSX) from April 2005 to September 2009, as regional training manager at Covidien （Shanghai） Management Consulting Co., Ltd., which was acquired by Medtronic Inc., a medical device company listed on the New York Stock Exchange(ticker symbol: MDT) in 2014, from September 2009 to March 2011, and as Asia Pacific training manager, marketing director, sales director successively at St. Jude Medical (Hong Kong) Limited, which was acquired by Abbott Laboratories, a medical device company listed on the New York Stock Exchange (ticker symbol: ABT), from March 2011 to January 2018.
Mr. Wu obtained a bachelor’s degree in pediatrics from Shanghai Second Medical University (上海第二医科大学) (currently, known as Shanghai Jiao Tong University School of Medicine (上海交通大学医学院)) in China in July 1998.